Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Pharmaceutical ETF (PPH)

56.00
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
50.35
Today|||52-Week Range
60.47
+6.65%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS-¤ US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Pharma ETFs Down Post Q3 Earnings
Nov 09 / Zacks.com - Paid Partner Content
What Lies in Store for Pharma ETFs?
Nov 07 / Zacks.com - Paid Partner Content

Performance

1 month-2.89% 3 years-2.47%
3 months+2.21% 5 years+10.16%
1 year+7.04% Since inception+10.17%
Data through 11/17/2017

Quote Details

Previous close$56.00
Open day’s range55.73 – 56.00
Net asset value (NAV)55.87 (11/16/2017)
Daily volume5,276
Average volume (3 months)59,974
Data as of 3:56pm ET, 11/17/2017

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return+10.16%+16.79%
Expense Gross exp ratio0.41%1.33%
Risk 5 year sharpe ratio0.691.11
Net assets$264.5M$3.1B
Average market cap$47.1B$27.3B
Average P/E22.422.4
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
ABBV AbbVie5.90%
AZN AstraZeneca5.73%
JNJ Johnson & Johnson5.38%
NVO Novo Nordisk5.24%
PFE Pfizer5.20%
BMY Bristol-Myers Squibb5.19%
MYL Mylan NV5.02%
NVS Novartis4.96%
SNY Sanofi4.82%
PRGO Perrigo Company PLC4.69%